Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Chemotherapy for ctDNA-Positive Stage I/II Colorectal Cancer
NCT03748680Phase 2Unknown
- Start
- Oct 2018
- Primary completion
- Oct 2023
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, capecitabine, fluorouracil, folinic acid in colorectal cancer (CRC). Status: unknown.
02
Drugs
oxaliplatincapecitabinefluorouracilfolinic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03748680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03748680.